Bladder cancer prevention. Part I: what do I tell my patients about lifestyle changes and dietary supplements?
- 1 September 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 13 (5) , 363-378
- https://doi.org/10.1097/00042307-200309000-00003
Abstract
Comprehensive reviews of lifestyle changes and dietary supplements that may prevent bladder cancer are needed in order to facilitate discussions between clinicians and patients. Novel data exist that numerous lifestyle/diet and dietary supplements may lower the risk of this disease. For example, reducing arsenic exposure, incorporating dietary changes, and vitamin E supplements continue to accumulate research that supports their use with some patients at a higher risk for this disease. Regardless, smoking cessation seems to have the largest impact on reducing risk and incorporating these other changes after smoking cessation may reduce an individual's risk to an even greater extent. However, a large percentage of cases of individuals diagnosed with this cancer apparently have no known etiology. Diets lower in calories or possibly specific sub-types of fat, and higher in fruits and especially vegetables, seem to provide some protection. Other dietary/supplement options may affect risk, but these benefits could be seriously attenuated by smoking. Dietary selenium, but currently not selenium supplements, may also affect risk, especially in non-smokers. Dietary vitamin E, and vitamin E supplements, may provide some protection. Non-selective (e.g. non-steroidal anti-inflammatory drugs) and selective cyclooxygenase-2 inhibitors are generating interest because bladder tumors seem to contain higher concentrations of this enzyme. Drinking-water quality, especially arsenic concentrations, may seriously affect risk. Providing recommendations for patients with regard to some of these lifestyle modifications is currently recommended because the majority of these alterations are also recommended currently for cardiovascular or general oncology disease reduction.Keywords
This publication has 95 references indexed in Scilit:
- Breast cancer and NSAID use: a meta-analysisBritish Journal of Cancer, 2001
- Prevention of Bladder CancerNew England Journal of Medicine, 1999
- Fluid Intake and the Risk of Bladder Cancer in MenNew England Journal of Medicine, 1999
- Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl) nitrosamine-induced bladder carcinogenesis in ratsZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective studyBritish Journal of Cancer, 1992
- Arsenic: opportunity for risk assessmentArchives of Toxicology, 1991
- Dietary factors in the risk of bladder cancerNutrition and Cancer, 1989
- Effect of soybean feeding on experimental carcinogenesis—III. Carcinogenecity of nitrite and dibutylamine in mice: a histopathological studyEuropean Journal of Cancer and Clinical Oncology, 1988
- A nonmathematical view of mathematical models for cancerJournal of Chronic Diseases, 1987
- Serum Beta-Carotene, Vitamins a and E, Selenium, and the Risk of Lung CancerNew England Journal of Medicine, 1986